| Revenue growth | Value |
|---|---|
| 1Y (TTM) | -71% |
| 3Y CAGR | +41% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -84% |
| 3Y CAGR | +24% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹3,744.00 -64.70 (1.70%) | 17,417.08 | 23.69 | 4.14 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,220.00 -38.80 (1.72%) | 17,194.23 | 25.36 | 5.1 | ||
Natco PharmaNATCOPHARM | ₹781.50 -19.35 (2.42%) | 15,708.15 | 13.72 | 1.5 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,007.50 -32.00 (0.53%) | 15,108.25 | 89.07 | 17.31 |